# NTLA (Intellia Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Intellia Therapeutics, Inc. reported $52.89M in revenue and a net loss of $426.1M for the trailing twelve months ended September 30, 2026 (down 48.0% year over year), with a -821.2% operating margin.

- Canonical: https://convexityos.com/fundamentals/NTLA
- Markdown: https://convexityos.com/fundamentals/NTLA.md
- SEC CIK: 0001652130
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:25 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001652130&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $52.89M | -48.0% YoY |
| Operating Income | TTM | -$434.3M | -821.2% margin |
| Net Income | TTM | -$426.1M | -805.7% net margin |
| Diluted EPS | TTM | -$3.04 | Split-adjusted |
| Free Cash Flow | TTM | -$358.1M | -677.1% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $474.1M | Total debt: $230.1M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $67.67M | $57.88M | $36.27M | $52.12M | $33.05M | $57.99M | $43.10M | $30.43M | $26.12M | $16.48M |
| Cost of Revenue | -- | -- | -- | -- | $0 | $0 | $0 | $0 | -- | -- |
| **Gross Profit** | -- | -- | -- | -- | $33.05M | $57.99M | $43.10M | $30.43M | -- | -- |
| Research & Development | $388.9M | $466.3M | $435.1M | $420.0M | $229.8M | $150.4M | $108.4M | $89.11M | $67.65M | $31.84M |
| **Operating Income** | -$441.0M | -$534.3M | -$515.3M | -$458.2M | -$267.9M | -$136.6M | -$106.4M | -$90.87M | -$69.56M | -$32.16M |
| **EBITDA** | -$431.2M | -$524.0M | -$506.3M | -$450.6M | -$261.0M | -$130.3M | -$100.8M | -$86.41M | -$66.56M | -$31.05M |
| Interest Income | $29.20M | $47.81M | $49.83M | $8.54M | $1.28M | $2.35M | $6.83M | $5.53M | $2.01M | $525K |
| Income Before Tax | -- | -- | -- | -- | -- | -- | -- | -- | -$67.54M | -$31.63M |
| Income Tax Expense | $0 | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Net Income** | -$412.7M | -$519.0M | -$481.2M | -$474.2M | -$267.9M | -$134.2M | -$474.2M | -$85.34M | -$67.54M | -$31.63M |
| Basic EPS | -$3.81 | -$5.25 | -$5.42 | -$6.16 | -$3.78 | -$2.40 | -$2.11 | -$1.98 | -$1.88 | -$1.42 |
| **Diluted EPS** | -$3.81 | -$5.25 | -$5.42 | -$6.16 | -$3.78 | -$2.40 | -$2.11 | -$1.98 | -$1.88 | -$1.42 |
| Basic Shares Outstanding | 108.4M | 98.8M | 88.8M | 77.0M | 70.9M | 56.0M | 47.2K | 43.1M | 36.0M | 22.2M |
| Diluted Shares Outstanding | 108.4M | 98.8M | 88.8M | 77.0M | 70.9M | 56.0M | 47.2K | 43.1M | 36.0M | 22.2M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $7.16M | $7.66M | $15.05M | $23.02M | $13.78M | $14.24M | $16.63M | $12.87M |
| Research & Development | $83.35M | $82.59M | $80.74M | $88.65M | $94.75M | $97.03M | $108.4M | $116.9M |
| **Operating Income** | -$122.3M | -$112.8M | -$100.5M | -$98.71M | -$111.5M | -$110.0M | -$120.8M | -$136.4M |
| **EBITDA** | -$120.4M | -$110.7M | -$98.33M | -$96.33M | -$109.1M | -$107.5M | -$118.3M | -$133.9M |
| Interest Income | -- | $5.80M | $5.21M | $6.48M | $6.71M | $7.40M | $8.60M | $10.63M |
| Interest Expense | $611K | -- | -- | -- | $0 | -- | -- | -- |
| **Net Income** | -$127.5M | -$106.6M | -$96.23M | -$95.79M | -$101.3M | -$101.3M | -$114.3M | -$128.9M |
| Basic EPS | -$0.91 | -$0.80 | -$0.81 | -- | -$0.92 | -$0.98 | -$1.10 | -- |
| **Diluted EPS** | -$0.91 | -$0.80 | -$0.81 | -- | -$0.92 | -$0.98 | -$1.10 | -- |
| Basic Shares Outstanding | 140.2M | 133.5M | 118.5M | -- | 110.2M | 103.7M | 103.5M | -- |
| Diluted Shares Outstanding | 140.2M | 133.5M | 118.5M | -- | 110.2M | 103.7M | 103.5M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $155.5M | $189.2M | $226.7M | $523.5M | $123.4M | $160.0M | $57.23M | $58.86M | $340.7M | $273.1M |
| Short-Term Investments | $294.4M | $412.3M | $685.5M | $669.1M | $625.3M | $437.4M | $222.5M | $255.2M | -- | -- |
| **Cash & Short-Term Investments** | $449.9M | $601.5M | $912.2M | $1.19B | $748.7M | $597.4M | $279.7M | $314.1M | $340.7M | $273.1M |
| Accounts Receivable, Net | $9.47M | $8.52M | $36.46M | $3.77M | $2.03M | $2.13M | $4.62M | $7.55M | $10.47M | $6.45M |
| **Total Current Assets** | $527.7M | $639.9M | $998.3M | $1.22B | $769.3M | $616.5M | $289.5M | $325.0M | $354.8M | $281.3M |
| Property, Plant & Equipment, Net | $17.67M | $27.38M | $32.76M | $27.92M | $20.97M | $15.94M | $18.00M | $17.06M | $15.27M | $10.63M |
| Long-Term Investments | $155.2M | $260.2M | $99.86M | $69.34M | $337.4M | $0 | $4.75M | -- | -- | -- |
| Other Non-Current Assets | -- | -- | -- | -- | -- | $4.75M | $2.92M | $5.28M | $6.13M | $7.04M |
| **Total Non-Current Assets** | $314.4M | $551.2M | $302.6M | $303.3M | $525.2M | $59.80M | $44.80M | $22.34M | $21.41M | $17.66M |
| **Total Assets** | $842.1M | $1.19B | $1.30B | $1.52B | $1.29B | $676.3M | $334.3M | $347.3M | $376.2M | $299.0M |
| Accounts Payable | $20.25M | $14.59M | $7.45M | $5.15M | $9.65M | $10.46M | $3.94M | $2.71M | $2.17M | $4.65M |
| Deferred Revenue (Current) | $7.29M | $20.66M | $22.14M | $43.84M | $63.76M | $22.54M | $12.67M | $27.12M | $21.19M | $20.18M |
| **Total Current Liabilities** | $103.9M | $110.9M | $115.2M | $126.6M | $125.8M | $64.25M | $35.63M | $40.57M | $31.36M | $30.73M |
| Long-Term Debt | $0 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Deferred Revenue (Non-Current) | $0 | $18.26M | $38.85M | $19.93M | $63.48M | $51.39M | $16.14M | $28.81M | $44.11M | $58.11M |
| Other Non-Current Liabilities | -- | -- | -- | -- | $0 | -- | -- | $13K | $168K | $293K |
| **Total Non-Current Liabilities** | $66.85M | $208.2M | $135.6M | $158.0M | $128.4M | $85.00M | $28.77M | $28.82M | $44.28M | $58.40M |
| **Total Liabilities** | $170.7M | $319.1M | $250.8M | $284.5M | $254.2M | $149.2M | $64.40M | $69.39M | $75.64M | $89.13M |
| **Total Debt (incl. Leases)** | $93.33M | $210.2M | $115.3M | $130.7M | $74.02M | $39.30M | $18.38M | -- | -- | -- |
| Common Stock | $12K | $10K | $9.0K | $9.0K | $7.0K | $7.0K | $5.0K | $5.0K | $4.0K | $4.0K |
| Retained Earnings | -$2.59B | -$2.18B | -$1.66B | -$1.18B | -$703.0M | -$435.1M | -$300.9M | -$201.0M | -$121.1M | -$53.57M |
| Accumulated Other Comp. Income | $1.03M | $605K | -$2.26M | -$7.46M | -$2.63M | $1.0K | $261K | -$28K | -- | -- |
| **Total Stockholders' Equity** | $671.4M | $872.0M | $1.05B | $1.24B | $1.04B | $527.1M | $269.9M | $277.9M | $300.6M | $209.8M |
| Total Equity | $671.4M | $872.0M | $1.05B | $1.24B | $1.04B | $527.1M | $269.9M | $277.9M | $300.6M | $209.8M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $156.1M | $106.1M | $134.7M | $155.5M | $193.4M | $156.2M | $126.9M | $189.2M |
| Short-Term Investments | $318.0M | $331.6M | $241.3M | $294.4M | $317.7M | $303.5M | $376.9M | $412.3M |
| **Cash & Short-Term Investments** | $474.1M | $437.8M | $376.0M | $449.9M | $511.0M | $459.7M | $503.7M | $601.5M |
| Accounts Receivable, Net | $7.50M | $7.32M | $9.13M | $9.47M | $11.05M | $11.35M | $10.50M | $8.52M |
| **Total Current Assets** | $506.4M | $527.8M | $466.4M | $527.7M | $581.9M | $495.9M | $551.4M | $639.9M |
| Property, Plant & Equipment, Net | $13.92M | $15.06M | $15.52M | $17.67M | $20.42M | $22.81M | $25.12M | $27.38M |
| Long-Term Investments | $140.7M | $190.6M | $141.3M | $155.2M | $158.8M | $170.9M | $203.4M | $260.2M |
| **Total Non-Current Assets** | $396.2M | $329.3M | $292.3M | $314.4M | $343.3M | $402.9M | $434.8M | $551.2M |
| **Total Assets** | $902.6M | $857.2M | $758.8M | $842.1M | $925.3M | $898.9M | $986.2M | $1.19B |
| Accounts Payable | $12.55M | $11.71M | $18.80M | $20.25M | $13.26M | $9.80M | $12.36M | $14.59M |
| Deferred Revenue (Current) | $0 | $0 | $630K | $7.29M | $12.25M | $17.15M | $20.66M | $20.66M |
| **Total Current Liabilities** | $80.31M | $79.39M | $76.44M | $103.9M | $93.73M | $95.50M | $112.6M | $110.9M |
| Long-Term Debt | $73.73M | -- | -- | $0 | -- | -- | -- | -- |
| Deferred Revenue (Non-Current) | -- | -- | -- | $0 | $12.54M | $12.54M | $13.16M | $18.26M |
| **Total Non-Current Liabilities** | $209.2M | $50.07M | $61.40M | $66.85M | $83.13M | $88.14M | $93.65M | $208.2M |
| **Total Liabilities** | $289.5M | $129.5M | $137.8M | $170.7M | $176.9M | $183.6M | $206.2M | $319.1M |
| **Total Debt (incl. Leases)** | $230.1M | $73.41M | $80.49M | $93.33M | $97.97M | $102.6M | $119.3M | $210.2M |
| Common Stock | $14K | $14K | $12K | $12K | $12K | $10K | $10K | $10K |
| Retained Earnings | -$2.92B | -$2.79B | -$2.69B | -$2.59B | -$2.49B | -$2.39B | -$2.29B | -$2.18B |
| Accumulated Other Comp. Income | -$2.56M | -$1.03M | -$240K | $1.03M | $990K | $653K | $1.06M | $605K |
| **Total Stockholders' Equity** | $613.1M | $727.7M | $620.9M | $671.4M | $748.4M | $715.3M | $779.9M | $872.0M |
| Total Equity | $613.1M | $727.7M | $620.9M | $671.4M | $748.4M | $715.3M | $779.9M | $872.0M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$412.7M | -$519.0M | -$481.2M | -$474.2M | -$267.9M | -$134.2M | -$99.53M | -$85.34M | -$67.54M | -$31.63M |
| Depreciation & Amortization | $9.77M | $10.29M | $8.98M | $7.57M | $6.89M | $6.31M | $5.59M | $4.46M | $2.99M | $1.10M |
| Stock-Based Compensation | $80.22M | $154.3M | $134.1M | $91.40M | $47.01M | $19.90M | $15.09M | $17.05M | $15.32M | $6.71M |
| Change in Receivables | -$951K | $27.94M | -$32.69M | -$1.74M | $99K | $2.49M | $2.93M | $2.92M | -$4.02M | -$5.45M |
| Change in Payables | $5.99M | $6.80M | $2.52M | -$4.58M | $529K | $5.06M | $1.88M | $232K | -$488K | $1.78M |
| **Operating Cash Flow** | -$394.7M | -$348.9M | -$394.1M | -$333.3M | -$225.0M | -$49.91M | -$103.2M | -$61.26M | -$65.28M | $36.11M |
| Capital Expenditure | -$1.13M | -$5.78M | -$13.98M | -$13.56M | -$12.76M | -$3.58M | -$6.79M | -$6.36M | -$10.09M | -$6.17M |
| **Free Cash Flow** | -$395.9M | -$354.7M | -$408.1M | -$346.8M | -$237.8M | -$53.50M | -$110.0M | -$67.61M | -$75.37M | $29.94M |
| Acquisitions, Net | -- | -$287K | -$287K | -$287K | -- | -- | -- | -- | -- | -- |
| Purchases of Investments | -$322.5M | -$935.6M | -$904.5M | -$429.0M | -$1.02B | -$473.7M | -$297.0M | -$254.6M | -- | -- |
| **Investing Cash Flow** | $228.0M | $125.6M | -$31.35M | $160.3M | -$550.8M | -$214.5M | $25.18M | -$260.8M | -$10.09M | -$6.17M |
| Common Stock Issued | $128.2M | $176.9M | $119.8M | -- | $1.82B | -- | $72.26M | $28.55M | $141.0M | $170.5M |
| **Financing Cash Flow** | $131.5M | $185.7M | $130.3M | $583.0M | $736.7M | $371.8M | $76.43M | $40.22M | $143.0M | $167.3M |
| **Net Change in Cash** | -$35.22M | -$37.57M | -$295.1M | $410.0M | -$39.12M | $107.4M | -$1.63M | -$281.8M | $67.61M | $197.2M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$127.5M | -$106.6M | -$96.23M | -$95.79M | -$101.3M | -$101.3M | -$114.3M | -$128.9M |
| Depreciation & Amortization | $1.90M | $2.10M | $2.20M | $2.38M | $2.40M | $2.50M | $2.50M | $2.57M |
| Stock-Based Compensation | $14.40M | $18.07M | $13.48M | $16.74M | $19.60M | $22.04M | $21.84M | $39.62M |
| Change in Receivables | -$178K | $1.81M | $337K | $1.58M | $303K | -$849K | -$1.99M | $337K |
| Change in Payables | -$661K | -$7.09M | -$1.42M | $6.96M | $3.46M | -$2.56M | -$1.87M | $1.44M |
| **Operating Cash Flow** | -$85.43M | -$83.11M | -$117.3M | -$69.28M | -$76.90M | -$99.62M | -$148.9M | -$85.19M |
| Capital Expenditure | -$888K | -$1.81M | -$79K | -$126K | -$29K | -$239K | -$735K | -$981K |
| **Free Cash Flow** | -$86.32M | -$84.92M | -$117.4M | -$69.41M | -$76.93M | -$99.86M | -$149.7M | -$86.18M |
| Purchases of Investments | -$53.97M | -$220.4M | -$46.97M | -$67.05M | -$116.7M | -$55.60M | -$83.21M | -$169.1M |
| **Investing Cash Flow** | $61.94M | -$141.6M | $66.31M | $27.53M | -$741K | $106.9M | $94.33M | $151.6M |
| **Financing Cash Flow** | $73.46M | $196.1M | $33.57M | $1.98M | $114.9M | $14.65M | $0 | $2.32M |
| **Net Change in Cash** | $49.97M | -$28.57M | -$17.47M | -$39.77M | $37.22M | $21.94M | -$54.60M | $68.69M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | -- | 100.0% | 100.0% | 100.0% | 100.0% | -- | -- |
| **Operating Margin** | -651.7% | -923.1% | -1420.5% | -879.0% | -810.4% | -235.5% | -246.8% | -298.6% | -266.3% | -195.2% |
| **Net Profit Margin** | -609.9% | -896.8% | -1326.5% | -909.8% | -810.5% | -231.5% | -1100.1% | -280.4% | -258.6% | -192.0% |
| Return on Equity (ROE) | -61.5% | -59.5% | -45.8% | -38.4% | -25.8% | -25.5% | -175.7% | -30.7% | -22.5% | -15.1% |
| Return on Assets (ROA) | -49.0% | -43.6% | -37.0% | -31.2% | -20.7% | -19.8% | -141.9% | -24.6% | -18.0% | -10.6% |
| Current Ratio | 5.08x | 5.77x | 8.67x | 9.61x | 6.11x | 9.59x | 8.12x | 8.01x | 11.32x | 9.15x |
| Quick Ratio | 4.42x | 5.50x | 8.23x | 9.45x | 5.97x | 9.33x | 7.98x | 7.93x | 11.20x | 9.10x |
| Debt to Equity | 0.14x | 0.24x | 0.11x | 0.11x | 0.07x | 0.07x | 0.07x | -- | -- | -- |
| **Revenue Growth (YoY)** | +16.9% | +59.6% | -30.4% | +57.7% | -43.0% | +34.5% | +41.6% | +16.5% | +58.5% | -- |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -43.0% | +34.5% | +41.6% | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -- | -280.8% | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -- | -351.7% | -- |
| 5Y Revenue / Share Growth | -39.7% | -99.9% | -42.2% | -6.6% | -37.1% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -821.2% | -711.7% | -636.6% | -651.7% | -832.2% | -968.7% | -1187.4% | -923.1% |
| **Net Profit Margin** | -805.7% | -672.2% | -597.0% | -609.9% | -774.9% | -908.5% | -1154.1% | -896.8% |
| Return on Equity (ROE) | -69.5% | -55.0% | -63.5% | -61.5% | -59.6% | -67.1% | -67.4% | -59.5% |
| Return on Assets (ROA) | -47.2% | -46.7% | -52.0% | -49.0% | -48.2% | -53.4% | -53.3% | -43.6% |
| Current Ratio | 6.31x | 6.65x | 6.10x | 5.08x | 6.21x | 5.19x | 4.90x | 5.77x |
| Quick Ratio | 6.00x | 5.61x | 5.04x | 4.42x | 5.57x | 4.93x | 4.57x | 5.50x |
| Debt to Equity | 0.38x | 0.10x | 0.13x | 0.14x | 0.13x | 0.14x | 0.15x | 0.24x |
| **Revenue Growth (YoY)** | -48.0% | -46.2% | -9.5% | +78.8% | +51.3% | +104.8% | -42.5% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
